Labshake search
Citations for R&D Systems :
251 - 300 of 585 citations for Factor B Bb Blocking Peptide since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2019Quote: ... and CXCR4 antagonist peptide AMD3100 were procured from R&D systems. All chemicals and antibodies were obtained from Sigma unless specified otherwise.
-
bioRxiv - Cell Biology 2021Quote: ... cells were treated with 30 μM Latrunculin B (R&D Systems) dissolved in 0.1% DMSO at 30°C for 1 hour ...
-
bioRxiv - Molecular Biology 2021Quote: ... and 10x E3 Ligase Reaction Buffer (R&D systems B-71). Addition of Rik1-TAP complex purified from S ...
-
bioRxiv - Immunology 2020Quote: ... or 100 U/mL human recombinant Ifn-b (R&D systems). Cells were harvested 18 hrs post-transfection ...
-
bioRxiv - Immunology 2020Quote: ... or 100 U/mL human recombinant Ifn-b (R&D systems) at the cell counts and conditions previously described for the cellular luciferase assays ...
-
bioRxiv - Microbiology 2020Quote: ... 50 µL of each solution A and B (R&D Systems) was added into each well ...
-
bioRxiv - Developmental Biology 2022Quote: ... and 100ng/mL TGFB1 (R&D Systems, Cat#240-B-002) in 3F media for 3 days ...
-
bioRxiv - Developmental Biology 2022Quote: ... and 100ng/mL TGFβ1 (R&D Systems, Cat#240-B-002) in 3F media for 3 days ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 ng/ml TGF-β1 (240-B-010, R&D Systems) or 10ng/ml Sema3A (1250-S3-025,R&D Systems) ...
-
bioRxiv - Immunology 2020Quote: ... Granzyme B was activated using Cathepsin C/DPPI (R&D Systems) according to manufacturer instructions ...
-
bioRxiv - Developmental Biology 2023Quote: ... 100 ng/mL rhTGFβ1 (R&D Systems Cat#240-B-002), 100 ng/mL rhNOGGIN (produced in-house ...
-
bioRxiv - Genomics 2024Quote: ... TGF-β1-induced (10 ng/mL) (R&D systems, #240-B) SSc fibroblasts were treated with 20 μM Ro5-3335 (TOCRIS ...
-
bioRxiv - Neuroscience 2022Quote: ... 10µg/ml of a VEGF function-blocking antibody (R&D Systems MAB9947-SP) was added to differentiation media and 10µg/ml of control IgG (Biolegend 403501 ...
-
bioRxiv - Bioengineering 2023Quote: ... and a TGFβ blocking antibody (20 µg mL-1, #MAB1835, R&D Systems). Trastuzumab (#MAB9589 ...
-
bioRxiv - Immunology 2023Quote: ... 30 µg/ml of anti-LOX-1 blocking antibody (polyclonal, R&D Systems) or goat IgG isotype (Biolegend ...
-
bioRxiv - Neuroscience 2021Quote: ... and ciliary neurotrophic factor (10 ng/mL; R&D Systems; Cat. No. 257-NT-050). The MN culture medium was replaced every other day for 6 days and the MN cultures were characterized by immunocytochemistry as described below ...
-
bioRxiv - Immunology 2021Quote: ... or 50 ng/ml macrophage colony- stimulating factor (M-CSF; R&D Systems, Abingdon, UK), respectively ...
-
bioRxiv - Cell Biology 2019Quote: ... Q-VD-OPh and Tumor Necrosis Factor-alpha (TNFα) were obtained from R&D Systems. Ionomycin was purchased from Calbiochem ...
-
bioRxiv - Neuroscience 2020Quote: ... with addition of pen/strep and growth factor bFGF 10 ng/ml (R&D Systems). Medium was changed every third day and cells were enzymatically passaged using Accutase (Gibco) ...
-
bioRxiv - Neuroscience 2021Quote: ... and 100 ng/ml murine recombinant fibroblast growth factor 8b (FGF-8b, R&D Systems) for 7 days in vitro (DIV) ...
-
bioRxiv - Neuroscience 2021Quote: ... supplemented with growth factors at the following concentrations: LM-22A4 (2 μM, R&D Systems), GDNF (2 ng/mL ...
-
bioRxiv - Systems Biology 2020Quote: ... supplemented with growth factors at the following concentrations: LM-22A4 (2 µM, R&D Systems), GDNF (2 ng/mL ...
-
bioRxiv - Cancer Biology 2022Quote: ... human recombinant epidermal growth factor (20 ng/ml; #236-EG-01M, R&D systems, USA), human recombinant fibroblast growth factor (20 ng/ml ...
-
bioRxiv - Bioengineering 2019Quote: ... and 10 ng/ml fibroblast growth factor-2 (FGF-2, R&D Systems, Minneapolis, MN) (39 ...
-
bioRxiv - Developmental Biology 2019Quote: ... goat anti-Platelet derived growth factor receptor beta (PDGFRB, 1:1000, AF1042, R&D systems), rat anti-Plasmalemma vesicle associated protein (PLVAP ...
-
bioRxiv - Neuroscience 2020Quote: ... and ciliary neurotrophic factor (10 ng/mL; R&D Systems; Cat. No. 257-NT-050) for 6 days before single cell suspension preparation.
-
bioRxiv - Neuroscience 2021Quote: ... or 10 ng/mL recombinant rat platelet-derived growth factor (PDGF-aa) (R&D Systems) and 10 ng/mL FGF-2 (Peprotech ...
-
bioRxiv - Developmental Biology 2021Quote: ... goat anti-platelet derived growth factor receptor-beta (PDGFRB, 1:1000, AF1042, R&D Systems), goat anti-notch3 (NOTCH3 ...
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with 50 ng/mL recombinant human vascular endothelial growth factor (VEGF; R&D Systems), 10 μM Y-27632 ...
-
bioRxiv - Cancer Biology 2023Quote: ... supplemented with 25 ng/ml human macrophages colony-stimulating factor (M-CSF) (R&D Systems) for 4 days to stimulate macrophage differentiation ...
-
bioRxiv - Neuroscience 2023Quote: ... and 20 ng ml−1 basic fibroblast growth factor (FGF2; R&D Systems, 233-FB) for 16 d ...
-
bioRxiv - Neuroscience 2024Quote: ... and basic fibroblast growth factor (bFGF, 20 ng ml-1, R&D Systems, 233-FB) until day 24 ...
-
bioRxiv - Bioengineering 2023Quote: ... + 20 ng/ml recombinant mouse macrophage colony-stimulating factor (M-CSF, R&D systems, 416ML010)) for 6-7 days ...
-
bioRxiv - Neuroscience 2023Quote: ... 10 ng/ml of brain-derived neurotrophic factor (BDNF; 248-BDB-010, R&D Systems), and 10 ng/ml of glia cell line-derived neurotrophic factor (GDNF ...
-
bioRxiv - Neuroscience 2024Quote: ... and ciliary neurotrophic factor (10 ng/mL; R&D Systems; Cat. No. 257-NT-050). Culture medium was replaced every other day for 6 days and the resulting MNs were characterized by immunocytochemistry ...
-
bioRxiv - Cell Biology 2024Quote: ... and 10 ng/ml keratinocyte growth factor (R&D Systems Cat#251KG, Minneapolis, MN, USA). RHEs were cultured for ten additional days with media being changed every 2-3 days.
-
bioRxiv - Immunology 2023Quote: ... using either PCSK9 peptides or recombinant mPCSK9/hPCSK9 protein (R&D Systems) as the coating antigen ...
-
bioRxiv - Neuroscience 2022Quote: ... and 0.01 μg ml −1 of granulocyte macrophage colony-stimulating factor (GM-CSF; R&D Systems). After 7 days ...
-
bioRxiv - Neuroscience 2020Quote: ... and goat anti-platelet derived growth factor receptor-alpha (PDGFRα, R&D systems #AF1062, 1:200), in a PBS-based diluent buffer containing 10% normal donkey serum and 0.2% Triton-X100 ...
-
bioRxiv - Cell Biology 2022Quote: ... Recombinant mouse macrophage colony stimulating factor (rm-MCSF) was from R&D System (Cat. # 416-ML). Human highly oxidized LDL was obtained from KB Kalen Biomedical (Cat ...
-
bioRxiv - Genomics 2019Quote: ... and 10 ng/ml recombinant human transforming growth factor beta 3 (rhTGF-b3) (R&D Systems). Pellets were formed at the end of passage 6 ...
-
bioRxiv - Cell Biology 2021Quote: ... 10 ng/mL recombinant human insulin-like growth factor 1 (IGF-1) (R&D Systems, USA), and 10 μM SB431542 (Tocris ...
-
bioRxiv - Bioengineering 2020Quote: ... and recombinant epidermal growth factor (10 ng/ml; Cat#236-GMP-200, R&D Systems, USA). Cells at 70-80% confluency were harvested and total cell counts were obtained ...
-
bioRxiv - Bioengineering 2020Quote: ... recombinant basic fibroblast growth factor (10 ng/ml; Cat#233-GMP-025, R&D Systems, USA) and recombinant epidermal growth factor (10 ng/ml ...
-
bioRxiv - Molecular Biology 2021Quote: ... epidermal growth factor (EGF, 20 ng/mL, Cat. #236-EG; R&D Systems, Minneapolis, MN, USA), basic fibroblast growth factor (bFGF ...
-
bioRxiv - Neuroscience 2020Quote: ... 100μg/ml streptomycin and 50ng/ml macrophage colony stimulation factor 1 (m-CSF) (R&D System) in non-cell culture treated dishes ...
-
bioRxiv - Bioengineering 2020Quote: ... and 50 ng/mL macrophage colony-stimulating factor (M-CSF) (R&D Systems, Minneapolis, MN, USA) was added to each well ...
-
bioRxiv - Physiology 2021Quote: ... supplemented with bovine pituitary extract and epidermal growth factor (EGF) (R&D Systems, Minneapolis, MN, USA), 10−10 molL-1 cholera toxin (Calbiochem ...
-
bioRxiv - Physiology 2021Quote: ... 1% P/S antibiotics and 10 ng/ml basic fibroblast growth factor (bFGF) (R&D Systems). Human MPCs were trypsinized and incubated 30 min with biotinylated anti-human PDGFRα (BAF322 R&D Systems ...
-
bioRxiv - Immunology 2020Quote: ... and 25 ng/mL recombinant human leukemia inhibitory factor (LIF; R&D Systems; Minneapolis, MN, USA). ICs for M2b polarization were generated by mixing 1 µL of a 1.32 mg/mL solution of bovine serum albumin (BSA ...